Application of antisense technology to therapeutics
- 1 June 1995
- journal article
- Published by Elsevier in Molecular Medicine Today
- Vol. 1 (3) , 128-133
- https://doi.org/10.1016/s1357-4310(95)80090-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Phosphorothioate Oligodeoxynucleotides Bind to Basic Fibroblast Growth Factor, Inhibit Its Binding to Cell Surface Receptors, and Remove It from Low Affinity Binding Sites on Extracellular MatrixPublished by Elsevier ,1995
- Structure of the NF-κB p50 homodimer bound to DNANature, 1995
- Structure of NF-κB p50 homodimer bound to a κB siteNature, 1995
- Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.Journal of Clinical Investigation, 1994
- Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanismsNucleic Acids Research, 1994
- The discovery and characterization of a novel nucleotide-based thrombin inhibitorGene, 1993
- Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?Science, 1993
- Current concepts in antisense drug designJournal of Medicinal Chemistry, 1993
- Ablation of Transplanted HTLV-I Tax-Transformed Tumors in Mice by Antisense Inhibition of NF-κBScience, 1992
- NUCLEOSIDE PHOSPHOROTHIOATESAnnual Review of Biochemistry, 1985